Amneal Pharmaceuticals, Inc. (AMRX)
Pharmaceutical Preparations
Latest Price
$18.32
TTM P/E
49.51
Normalized P/E
--
Div Yield
--
Book Value
2.16
P/B Ratio
8.49
Valuation metrics
adjust assumptions →EPS: $0.22
Target P/E: 50×
Formula: EPS × P/E
P/E Fair Value
$11.00
40% downside
Institutional Ownership
49.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 24.52M | $304.0M | 7.76% | +10.22M | 2026-03-31 |
| TPG GP A, LLC | 12.33M | $153.0M | 3.90% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11.32M | $140.0M | 3.58% | -- | 2026-03-31 |
| Rubric Capital Management LP | 11.04M | $137.0M | 3.49% | -1.30M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.59M | $94.0M | 2.40% | -- | 2026-03-31 |
| STATE STREET CORP | 6.79M | $84.0M | 2.15% | +2.68M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 5.69M | $70.0M | 1.80% | +81.5K | 2026-03-31 |
| MORGAN STANLEY | 4.64M | $57.0M | 1.47% | -180.9K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.55M | $56.0M | 1.44% | +559.5K | 2026-03-31 |
| NEUBERGER BERMAN GROUP LLC | 3.68M | $45.0M | 1.17% | +26.9K | 2026-03-31 |